Editorial
Letter from the Editor-in-Chief

Dear Colleagues,



This issue of the Journal of Contemporary Brachytherapy consist of two parts: the first contains manuscripts and the second – materials from “International Meeting on Prostate Brachytherapy”, organized by Eckert & Ziegler BEBIG, which will be held in Mallorca, Spain, 21rd-23th November 2012. We continue publishing materials from a scientific conventions. We are open for a cooperation with any scientific society, a research team or a company which patronize a scientific meetings. You are most welcome to cooperate. Publishing of this materials does not mean in any matter a company preference.

Seven manuscripts are published in this issue – four clinical investigations concerning cervival cancer, endometrial cancer and prostate cancer: one about non isocentric film-based intracavitary brachytherapy planning in cervical cancer: a retrospective dosimetric analysis with CT planning, second about dosimetry and toxicity outcomes in postoperative High-Dose-Rate intracavitary brachytherapy for endometrial carcinoma, then one discussing benefits of a dual sagittal crystal transducer for ultrasound imaging during I-125 seed implantation for permanent prostate brachytherapy and one about proposed protocol on HDR cylinder treatments: proof of avoidance of re-planning of CT based fractionated treatment, using a critical and statistical and graphical analysis of clinical data. One review is published discussing brachytherapy in Accelerated Partial Breast Irradiation (APBI) – review of treatment methods. Two case reports are also published: one describing COMS plaque loading optimization for improved dose conformity and homogeneity and second about re-implantation of suboptimal prostate seed implantation: technique with intra-operative treatment planning.

Some important news from brachytherapy. HealthImaging (http://www.healthimaging.com) discussed an important issue – “Reimbursement cuts may limit brachytherapy use”. As we know, brachytherapy offers a cost-effective method of treating prostate cancer, and its popularity in the future will likely rely on its financial status, according to a report by GlobalData. The report, titled “Brachytherapy Devices – Global Opportunity Assessment, Competitive Landscape and Market Forecasts to 2018”, suggests the growing cost of cancer treatment has intensified focus on the cost-effectiveness of treatment approaches, and brachytherapy is shining through as the...


View full text...